Skip to content

Amesite Inc.: 10-Q filed 2026-02-06

What Amesite Inc. reported in its quarterly report filed 2026-02-06 (fiscal Q2 2026): 31 published measures, 94 facts as tagged in accession 0001213900-26-012916.

This filing

Form
10-Q (quarterly report)
Filed
2026-02-06
Fiscal period
fiscal Q2 2026
Accession
0001213900-26-012916 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Amesite Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-12-311,997,983USD
At 2025-06-303,097,099USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-12-311,508,193USD
At 2025-09-302,168,489USD
At 2025-06-302,738,503USD
At 2024-12-311,247,465USD
At 2024-09-302,328,107USD
At 2024-06-302,515,712USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-12-311,165,369USD
At 2025-06-302,333,418USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-10-01 to 2025-12-31-732,548USD92
2025-07-01 to 2025-12-31-1,374,814USD184
2025-07-01 to 2025-09-30-642,266USD92
2024-10-01 to 2024-12-31-1,121,637USD92
2024-07-01 to 2024-12-31-2,029,682USD184
2024-07-01 to 2024-09-30-908,045USD92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-07-01 to 2025-12-31-1,036,849USD184
2024-07-01 to 2024-12-31-1,338,711USD184

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2025-10-01 to 2025-12-31108,050USD92
2025-07-01 to 2025-12-31202,346USD184
2024-10-01 to 2024-12-3112,760USD92
2024-07-01 to 2024-12-3124,010USD184

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2025-07-01 to 2025-12-31-131,200USD184
2024-07-01 to 2024-12-31-212,599USD184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-12-31-42,825,401USD
At 2025-06-30-41,450,587USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-10-01 to 2025-12-314,572,713shares92
2025-07-01 to 2025-12-314,572,713shares184
2024-10-01 to 2024-12-312,792,440shares92
2024-07-01 to 2024-12-312,777,494shares184

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-10-01 to 2025-12-31-0.16USD/shares92
2025-07-01 to 2025-12-31-0.3USD/shares184
2024-10-01 to 2024-12-31-0.4USD/shares92
2024-07-01 to 2024-12-31-0.73USD/shares184

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-10-01 to 2025-12-31-0.16USD/shares92
2025-07-01 to 2025-12-31-0.3USD/shares184
2024-10-01 to 2024-12-31-0.4USD/shares92
2024-07-01 to 2024-12-31-0.73USD/shares184

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-12-3126,762USD
At 2025-06-3039,436USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2025-10-01 to 2025-12-3172,252USD92
2025-07-01 to 2025-12-31144,504USD184
2024-10-01 to 2024-12-3140,995USD92
2024-07-01 to 2024-12-31106,435USD184

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-10-01 to 2025-12-31-745,253USD92
2025-07-01 to 2025-12-31-1,407,377USD184
2024-10-01 to 2024-12-31-1,130,869USD92
2024-07-01 to 2024-12-31-2,058,213USD184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-12-311,331,723USD
At 2025-06-302,433,859USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-12-31489,790USD
At 2025-06-30358,596USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2025-12-3124,892USD
At 2025-06-3025,413USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2025-12-317,197USD
At 2025-06-306,341USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-10-01 to 2025-12-31853,303USD92
2025-07-01 to 2025-12-311,609,723USD184
2024-10-01 to 2024-12-311,143,629USD92
2024-07-01 to 2024-12-312,082,223USD184

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2025-10-01 to 2025-12-31164,853USD92
2025-07-01 to 2025-12-31267,741USD184
2024-10-01 to 2024-12-31211,867USD92
2024-07-01 to 2024-12-31351,525USD184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-12-314,572,713shares
At 2025-06-304,572,713shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2025-12-311,265,369USD
At 2025-06-302,433,418USD
At 2024-12-31619,706USD
At 2024-06-302,171,016USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-12-3144,333,136USD
At 2025-06-3044,188,632USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2025-12-31155,581USD
At 2025-06-30142,907USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2025-12-31159,157USD
At 2025-06-3094,100USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

PeriodValueUnitDays
At 2025-12-3116,125USD
At 2025-06-3036,745USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2025-10-01 to 2025-12-31578,940USD92
2025-07-01 to 2025-12-311,126,000USD184
2024-10-01 to 2024-12-31804,652USD92
2024-07-01 to 2024-12-311,437,774USD184

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2025-10-01 to 2025-12-316,337USD92
2025-07-01 to 2025-12-3112,674USD184
2024-10-01 to 2024-12-316,337USD92
2024-07-01 to 2024-12-3112,674USD184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2025-10-01 to 2025-12-3112,705USD92
2025-07-01 to 2025-12-3132,563USD184
2024-10-01 to 2024-12-319,232USD92
2024-07-01 to 2024-12-3128,531USD184

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2025-07-01 to 2025-12-31856USD184
2024-07-01 to 2024-12-31-30,060USD184

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2025-07-01 to 2025-12-31-521USD184
2024-07-01 to 2024-12-3195,878USD184

Inspect the source

Entity
Amesite Inc. / CIK 0001807166
Captured
2026-09-21T17:28:03.682Z
SEC response SHA-256
461c5975337814f2ee2af0d6667a281ad65728a8a27803451b3699350e7124cc

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001807166.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))